Doctor, Epidemiologist, Public health professional, FETP faculty, Implementation science, GMKMC & JIPMER alumni, Tweets are personal
Jul 4, 2021 • 10 tweets • 6 min read
Just got to read through the pre-print of COVAXIN phase 3 trial. Yes, it's reassuring that the efficacy against symptomatic COVID-19 is 77.8% and over 65% Delta variant. But, as a reader, I always wish to review through the methodology before interpreting the results (1/n)
Authors have defined symptomatic COVID-19 case as presence of at least two of the selected symptoms. It was not clear from the article whether an individual with only one symptom and tested positive was included in the analysis. Also, no definition given for severe COVID-19 (2/n)
May 15, 2021 • 16 tweets • 6 min read
Do vaccines really work? Does the benefit outweigh adverse effects? - A thread on how effective is the COVID-19 vaccine. I am not going to speak numbers or statistics. If you are here to listen to stories beyond numbers, hear me out #vaccinestories#vaccinechain
I am going to tell you four stories - mine and three of my close friends
Scenario at family of Friend 1:
Parents denied vaccination after repeated requests. His mother developed symptoms, but she denied and delayed testing for more than a week. But he was monitoring O2 saturation
